Owlet, Inc. income statement
In fiscal 2025, Owlet, Inc. reported revenue of $106m, up 37.1% on the year before, operating income of −$7.4m (a -7.0% margin) and net income of −$38.8m, or −$2.27 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 75 | 76 | 69 | 54 | 77 | 106 | 115 |
| Cost of revenue | 40 | 41 | 46 | 31 | 39 | 52 | 52 |
| Gross profit | 36 | 35 | 23 | 23 | 39 | 54 | 63 |
| Research and development | 10 | 21 | 28 | 10 | 10 | 14 | 16 |
| Selling and marketing | 19 | 37 | 38 | 14 | 16 | 18 | 21 |
| General and administrative | 13 | 32 | 42 | 27 | 34 | 29 | 34 |
| Operating income | −7 | −56 | −85 | −29 | −21 | −7 | −7 |
| Interest expense | 1 | 2 | 1 | 3 | 2 | 1 | 0 |
| Net interest income | — | — | — | — | −1 | — | — |
| Income before tax | −11 | −72 | −79 | −33 | −13 | −39 | −9 |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | −11 | −72 | −79 | −33 | −13 | −39 | −9 |
| Diluted EPS | −$2.24 | −$15.82 | −$9.98 | −$4.53 | −$1.59 | −$2.27 | −$0.36 |
| Diluted shares (average) | 5m | 5m | 8m | 8m | 11m | 18m | 24m |
| EBITDA | −6 | −55 | −83 | −28 | −20 | −7 | −7 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 22 | 20 | 22 | 26 | 32 | 27 | 22 | 34 |
| Cost of revenue | 11 | 10 | 10 | 13 | 16 | 14 | 10 | 12 |
| Gross profit | 12 | 10 | 12 | 13 | 16 | 13 | 12 | 22 |
| Research and development | 3 | 2 | 3 | 4 | 4 | 4 | 4 | 5 |
| Selling and marketing | 4 | 4 | 4 | 4 | 5 | 5 | 4 | 6 |
| General and administrative | 10 | 12 | 7 | 7 | 6 | 9 | 9 | 10 |
| Operating income | −5 | −8 | −2 | −2 | 1 | −5 | −5 | 2 |
| Interest expense | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net interest income | −0 | −1 | −1 | −1 | −1 | — | −1 | −1 |
| Income before tax | −6 | −9 | 4 | −37 | 4 | −9 | −3 | −1 |
| Income tax | 0 | 0 | 0 | 0 | 0 | −0 | 0 | 0 |
| Net income | −6 | −9 | 4 | −37 | 4 | −9 | −3 | −1 |
| Diluted EPS | −$0.61 | −$0.80 | $0.14 | −$2.35 | −$0.05 | −$0.29 | −$0.24 | −$0.05 |
| EBITDA | −5 | −8 | −2 | −2 | 1 | −5 | −5 | 2 |
Compare with peers
- Outset Medical, Inc. income statement
- Sanara Medtech Inc. income statement
- Xtant Medical Holdings, Inc. income statement
- Anika Therapeutics, Inc. income statement
- Beta Bionics, Inc. income statement
Head to head: OM vs OWLTOWLT vs SMTIOWLT vs XTNTANIK vs OWLT
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies